Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Business Wire
Revenue of $401.6 million, up 77% year-over-year in Q3 2024Net income of $75.6 million; Adjusted EBITDA of $51.1 million in Q3 2024Subscribers grew to 2.0 million, up 44% year-over-year in Q3 2024Raises full year 2024 revenue guidance to a range of $1.460 billion to $1.465 billion and Adjusted EBITDA guidance to a range of $173 million to $178 million SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2024 in a shareholder letter that is posted at investors.hims.com.“Improving momentum in both the Hims and Hers brands delivered another strong quarter of growth and profitability,” said Andrew Dudum, co-founder and CEO. “Our execution against a strategy that brings customers convenient, transparent, and affordable access to care designed specifically for them is allowing us to reach millions of individuals across the
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- What's Going On With Hims & Hers Health Stock On Wednesday? [Yahoo! Finance]Yahoo! Finance
- Americans Continue to Struggle to Access Branded GLP-1s as Shortages ContinueBusiness Wire
- Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality [Yahoo! Finance]Yahoo! Finance
- Earnings Estimates Moving Higher for Hims & Hers Health (HIMS): Time to Buy? [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at TD Cowen from $25.00 to $28.00. They now have a "buy" rating on the stock.MarketBeat
HIMS
Earnings
- 11/4/24 - Beat
HIMS
Sec Filings
- 11/13/24 - Form 144
- 11/13/24 - Form 4
- 11/13/24 - Form 4
- HIMS's page on the SEC website